Site identity card

Centre Hospitalier Agen – Nérac

Agen, France
Share

Clinical Studies (1)

  • CoCoPrev : Study aims to assess the impact of monoclonal antibodies and direct antiviral therapies on clinical and virological outcomes in high-risk patients with early mild-to-moderate COVID-19, including sequencing to identify viral population changes and emerging minority variants.

Study Data

  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to